FACET PHARMA ApS: Financial statements 2023
CVR: 66387119
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
FACET PHARMA ApS (CVR 66387119) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -28,877 and a net result of DKK -10,193 compared with DKK -71,912 the year before. Equity in the 2023 report amounted to DKK 254,565. The solvency ratio was 53.3%.
- Gross Profit
- DKK -28,877
- Profit/Loss
- DKK -10,193
- Equity
- DKK 254,565
- Total Assets
- DKK 477,470
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -29K | -10K | 255K | 0 |
| 2022 | - | -58K | -72K | 265K | 0 |
| 2021 | - | -18K | -30K | 337K | 1 |
| 2020 | - | 50K | 30K | 367K | 0 |
| 2019 | - | 73K | -216K | 336K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
FACET PHARMA ApS has published its annual report for 2022. Gross profit came to DKK -58,103, and the net result was DKK -71,912.
About FACET PHARMA ApS
FACET PHARMA ApS was a Danish company of the type Anpartsselskab based in Brøndby, founded in 1980. The company has been dissolved on 21 February 2025. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -28,877 and a net result of DKK -10,193 compared with DKK -71,912 the year before. Equity in the 2023 report amounted to DKK 254,565.